Stock Track | PHARMARON (03759) Soars 9.14% as Share Buyback Plan Boosts Investor Confidence

Stock Track2024-12-09

The Hong Kong stock market opened lower on Monday, with the Hang Seng Index (HSI) falling by 0.67%. However, pharmaceutical and biotech stocks bucked the trend, with PHARMARON (03759) surging 9.14% in the morning session.

The surge in PHARMARON's stock was fueled by the company's announcement to repurchase its H-shares with a maximum amount of RMB 50 million. This share buyback plan signaled the management's confidence in the company's future prospects, boosting investor sentiment and driving up the stock price.

PHARMARON's strong performance was part of a broader rally in the pharmaceutical and biotech sectors. Other notable gainers included Wuxi Biologics (02269), which rose 13.03% after reporting robust financial results, and Innovent Biologics (01801), which gained 2.38% following positive clinical trial results for one of its key drug candidates.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1110155320?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-09 09:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1110155320","market":"hk","top_or_hot":-1,"title":"Stock Track | PHARMARON (03759) Soars 9.14% as Share Buyback Plan Boosts Investor Confidence","media":"Stock Track","content":"<p>The Hong Kong stock market opened lower on Monday, with the Hang Seng Index (HSI) falling by 0.67%. However, pharmaceutical and biotech stocks bucked the trend, with PHARMARON (03759) surging 9.14% in the morning session.</p>\n\n<p>The surge in PHARMARON's stock was fueled by the company's announcement to repurchase its H-shares with a maximum amount of RMB 50 million. This share buyback plan signaled the management's confidence in the company's future prospects, boosting investor sentiment and driving up the stock price.</p>\n\n<p>PHARMARON's strong performance was part of a broader rally in the pharmaceutical and biotech sectors. Other notable gainers included Wuxi Biologics (02269), which rose 13.03% after reporting robust financial results, and Innovent Biologics (01801), which gained 2.38% following positive clinical trial results for one of its key drug candidates.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | PHARMARON (03759) Soars 9.14% as Share Buyback Plan Boosts Investor Confidence</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | PHARMARON (03759) Soars 9.14% as Share Buyback Plan Boosts Investor Confidence\n</h2>\n\n<h4 class=\"meta\">\n\n2024-12-09 09:31 北京时间&nbsp;&nbsp;&nbsp;<strong>Stock Track</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Hong Kong stock market opened lower on Monday, with the Hang Seng Index (HSI) falling by 0.67%. However, pharmaceutical and biotech stocks bucked the trend, with PHARMARON (03759) surging 9.14% in...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03759","symbol_name":"康龙化成","start_time":0,"source_url":"","article_id":"1110155320","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1110155320","pubTimestamp":1733707871,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"The Hong Kong stock market opened lower on Monday, with the Hang Seng Index  falling by 0.67%. However, pharmaceutical and biotech stocks bucked the trend, with PHARMARON  surging 9.14% in the morning session.The surge in PHARMARON's stock was fueled by the company's announcement to repurchase its H-shares with a maximum amount of RMB 50 million. This share buyback plan signaled the management's confidence in the company's future prospects, boosting investor sentiment and driving up the stock pr","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03759":"康龙化成"},"translate_title":"股票赛道康龙化成(03759)大涨9.14%股票回购计划提振投资者信心","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03759":1},"content_text":"The Hong Kong stock market opened lower on Monday, with the Hang Seng Index (HSI) falling by 0.67%. However, pharmaceutical and biotech stocks bucked the trend, with PHARMARON (03759) surging 9.14% in the morning session.\nThe surge in PHARMARON's stock was fueled by the company's announcement to repurchase its H-shares with a maximum amount of RMB 50 million. This share buyback plan signaled the management's confidence in the company's future prospects, boosting investor sentiment and driving up the stock price.\nPHARMARON's strong performance was part of a broader rally in the pharmaceutical and biotech sectors. Other notable gainers included Wuxi Biologics (02269), which rose 13.03% after reporting robust financial results, and Innovent Biologics (01801), which gained 2.38% following positive clinical trial results for one of its key drug candidates.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1110155320"}